Allspring Global Investments Holdings, LLC Point Biopharma Global Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023
BUY
$6.67 - $9.71 $518,499 - $754,816
77,736 New
77,736 $518,000
Q2 2023

Jul 18, 2023
BUY
$6.86 - $10.86 $412,731 - $653,391
60,165 Added 107.65%
116,053 $1.05 Million
Q1 2023

Apr 13, 2023
SELL
$6.78 - $8.1 $36,713 - $43,861
-5,415 Reduced 8.83%
55,888 $406,000
Q4 2022

Jan 23, 2023
SELL
$5.72 - $9.78 $1,258 - $2,151
-220 Reduced 0.36%
61,303 $447 Million
Q3 2022

Oct 26, 2022
BUY
$7.24 - $10.31 $445,426 - $634,302
61,523 New
61,523 $475,000

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0
View Full List

About POINT Biopharma Global Inc.

PNT Quotes by TradingView
  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email